Birdwatch Note
2023-03-08 20:22:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin and hydroxychloroquine have repeatedly been shown to be ineffective at treating COVID-19. The OP profits greatly from having written thousands of ivermectin and hydroxychloroquine prescriptions. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://emergency.cdc.gov/newsletters/coca/020122.htm https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and https://www.medpagetoday.com/special-reports/exclusives/103353 https://www.nejm.org/doi/full/10.1056/NEJMc2114907
Written by 55CDB0C1B5A58436987B00C63EBDD3980BF71CC3A30D4EE3BD4BA7D33AAEBCAD
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1633372186567163904
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1633563866029346816
- noteId - 1633563866029346816
- participantId - 55CDB0C1B5A58436987B00C63EBDD3980BF71CC3A30D4EE3BD4BA7D33AAEBCAD
- noteAuthorParticipantId -
- createdAtMillis - 1678306950466
- tweetId - 1633372186567163904
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin and hydroxychloroquine have repeatedly been shown to be ineffective at treating COVID-19. The OP profits greatly from having written thousands of ivermectin and hydroxychloroquine prescriptions. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://emergency.cdc.gov/newsletters/coca/020122.htm https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and https://www.medpagetoday.com/special-reports/exclusives/103353 https://www.nejm.org/doi/full/10.1056/NEJMc2114907
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-08 20:22:30 UTC (1678306950466) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-09 02:09:52 UTC (1678327792328) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-10 23:54:14 -0600 | 04E2677FECB361D0C3F2917DE54010C0150E653D5BCBAA8214B937B8F8611EAB | Rating Details |
| 2023-03-10 23:54:47 -0600 | 0E3D268AE0A5CFBA11DCBB42E6EB1DA36B118A1775BD01D9E9188742DD168F33 | Rating Details |
| 2023-03-10 23:19:23 -0600 | 0E863B002F0453AAFD9D27131B4B315147C9D437C3910DF72871117C5C39CE66 | Rating Details |
| 2023-03-09 10:28:38 -0600 | 17E7659760800352338295D973AA8270BED44209140A5CEF437B36CA15889EA2 | Rating Details |
| 2023-03-10 23:04:50 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
| 2023-03-10 03:11:15 -0600 | 25BB127132A919E13A0F95968D39AB41C3C258706013CE9131271FB395AE7859 | Rating Details |
| 2023-03-10 22:31:18 -0600 | 2EBF26F60F3A7E9005DA089FC61E341428510E1CA440226B1C2CB0CD463748D6 | Rating Details |
| 2023-03-08 19:09:38 -0600 | 2F3F0EA294A1DFBF35BBFB976534645C6A322482304ED05DADF85BE033EFFF3C | Rating Details |
| 2023-03-09 16:12:11 -0600 | 352E5F6DE55CA5DF28078A5B1747522318F698E9684936BCF65A9A5FAFCE3EE9 | Rating Details |
| 2023-03-10 23:35:15 -0600 | 373B7DE50DC490C95349BF11A8506D7AE8CF893E3549D14DAF3F504E1DE61796 | Rating Details |
| 2023-03-10 02:16:37 -0600 | 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 | Rating Details |
| 2023-03-09 21:09:59 -0600 | 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 | Rating Details |
| 2023-03-10 21:47:52 -0600 | 46F0DC2E2D70C72230C79A6A095CB48DF62F70780D4D060F0066947AE4F2BD77 | Rating Details |
| 2023-03-09 06:17:50 -0600 | 57263F9900C72E9AD56537246336874165244B362189EC0F0A1FE5BA9FBC1176 | Rating Details |
| 2023-03-09 22:02:56 -0600 | 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 | Rating Details |
| 2023-03-11 00:37:08 -0600 | 6361E24B10267366034475DFF80A430CD0A757429D12CFAD95CD144862D9925F | Rating Details |
| 2023-03-11 00:54:04 -0600 | 649BDE2F4CE6EF6D24E4BC9637AEAE35F513702D98F7683E9A353C2116D1BD26 | Rating Details |
| 2023-03-09 00:40:18 -0600 | 6704AA9E372154070FE44E5AF26342937FD8C7B54C8D8066DA748C1108B26110 | Rating Details |
| 2023-03-09 21:56:28 -0600 | 69BB4ECC43787E521898154CE831A376E659437CA1AED00A1120F09A7C7672EA | Rating Details |
| 2023-03-10 04:14:05 -0600 | 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061 | Rating Details |
| 2023-03-10 23:29:22 -0600 | 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C | Rating Details |
| 2023-03-09 20:55:01 -0600 | 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 | Rating Details |
| 2023-03-10 23:58:15 -0600 | 83F8C9FBF04EDF7CE0402610D70596E31ACF4323833A5EAB7FFC83BF5104A1FC | Rating Details |
| 2023-03-08 15:49:48 -0600 | 862E84AD6C488AB3037EAC4682346692F09F61D556BF80E01E4F8B21C28D08CA | Rating Details |
| 2023-03-08 15:50:28 -0600 | 871543A3F1E63A664AFB1848387909DFA9D14C01FE31F3D519631D21E79662D2 | Rating Details |
| 2023-03-08 14:49:28 -0600 | 8B0C708F7C4499572AFA7FEFAF47D48BFC8CD53CB3CB8CF7A2E43145A3D25E7A | Rating Details |
| 2023-03-09 23:18:38 -0600 | 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 | Rating Details |
| 2023-03-08 15:43:24 -0600 | 9AD595B701167DE73F25FC67E8E758737FE297EB40C6B14DFA15EAE009148C91 | Rating Details |
| 2023-03-10 22:17:47 -0600 | 9B5E7654114B589A3A4E99761C67F6947C8929874AA1F71C4EBE23FA3F1CCB69 | Rating Details |
| 2023-03-08 15:51:57 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2023-03-10 08:54:50 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2023-03-08 18:36:06 -0600 | AA8F211FBCD534B53CFC33C35A6DE3B250B3EC558B1335065FE6916618B0A9EE | Rating Details |
| 2023-03-08 15:45:47 -0600 | AC19FDD95924A08EAD5BFE1476344C938474CC97AFD720F2280568C2EEF8FBD1 | Rating Details |
| 2023-03-11 00:14:46 -0600 | B05E5A9FEAD2BBD12C27CCE2AF5EC06458B98D232AA85096BCC6FF412C1BEF6A | Rating Details |
| 2023-03-09 21:27:45 -0600 | C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 | Rating Details |
| 2023-03-09 23:39:48 -0600 | C44966D101B6D79138B05AD90C60F5239A8DCF767672690390740E6EA47673AB | Rating Details |
| 2023-03-10 22:36:29 -0600 | C4AB10E196962EA212F4C3584870BD8DB89E319FC530438A8AA8E5A0F039EEC9 | Rating Details |
| 2023-03-09 21:31:24 -0600 | C90C535484C4D52ED31381955CA67F06C8A969E1220D779EE2B05BE1BBDD4DEF | Rating Details |
| 2023-03-10 10:10:00 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
| 2023-03-11 00:10:23 -0600 | D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 | Rating Details |
| 2023-03-10 23:04:51 -0600 | DED02447B6E5427B0E780F7ED69CBB4CBCEA6575BDF3F728311897471FC29442 | Rating Details |
| 2023-03-09 16:56:43 -0600 | F9BA0544FB2D46CF3937C0D4E24C3DA7B1376A7695546E6D6682A5A00BBABBF6 | Rating Details |
| 2023-03-08 16:39:40 -0600 | FAC6CA47623CF04637757B88A33A4B845545EAD5E885980FFFFDE1976952656A | Rating Details |
| 2023-03-10 22:14:54 -0600 | FE2879C337844B80A8A3017D0A3989836395C07BFB78700345FD47046E8C47BA | Rating Details |
| 2023-03-10 23:00:43 -0600 | FF6E19F158BFF55BD3EB79A4E772F94D88276C0B4FDA42A51CAA364E0ED5D54A | Rating Details |
| 2023-03-14 02:29:01 -0500 | Rating Details | |
| 2023-03-13 21:15:53 -0500 | Rating Details | |
| 2023-03-21 18:19:23 -0500 | Rating Details | |
| 2023-03-21 16:39:43 -0500 | Rating Details | |
| 2023-03-21 21:55:48 -0500 | Rating Details | |
| 2023-03-21 20:34:08 -0500 | Rating Details | |
| 2023-03-21 20:02:29 -0500 | Rating Details | |
| 2023-04-07 20:24:44 -0500 | Rating Details | |
| 2023-03-10 23:54:47 -0600 | Rating Details | |
| 2023-03-10 10:10:00 -0600 | Rating Details | |
| 2023-03-10 22:17:47 -0600 | Rating Details | |
| 2023-03-10 23:04:50 -0600 | Rating Details | |
| 2023-03-09 21:09:59 -0600 | Rating Details | |
| 2023-03-08 16:39:40 -0600 | Rating Details | |
| 2023-03-08 15:50:28 -0600 | Rating Details | |
| 2023-03-09 21:56:28 -0600 | Rating Details | |
| 2023-03-09 16:56:43 -0600 | Rating Details | |
| 2023-03-21 16:39:43 -0500 | Rating Details | |
| 2023-03-08 18:36:06 -0600 | Rating Details | |
| 2023-03-09 23:39:48 -0600 | Rating Details | |
| 2023-03-09 06:17:50 -0600 | Rating Details | |
| 2023-03-08 14:49:28 -0600 | Rating Details | |
| 2023-03-11 00:54:04 -0600 | Rating Details | |
| 2023-04-07 20:24:44 -0500 | Rating Details | |
| 2023-03-11 00:10:23 -0600 | Rating Details | |
| 2023-03-10 08:54:50 -0600 | Rating Details | |
| 2023-03-14 02:29:01 -0500 | Rating Details | |
| 2023-03-09 21:27:45 -0600 | Rating Details | |
| 2023-03-10 02:16:37 -0600 | Rating Details | |
| 2023-03-21 20:34:08 -0500 | Rating Details | |
| 2023-03-10 22:36:29 -0600 | Rating Details | |
| 2023-03-10 22:14:54 -0600 | Rating Details | |
| 2023-03-10 03:11:15 -0600 | Rating Details | |
| 2023-03-08 15:45:47 -0600 | Rating Details | |
| 2023-03-08 19:09:38 -0600 | Rating Details | |
| 2023-03-10 23:04:51 -0600 | Rating Details | |
| 2023-03-09 20:55:01 -0600 | Rating Details | |
| 2023-03-11 00:37:08 -0600 | Rating Details | |
| 2023-03-09 10:28:38 -0600 | Rating Details | |
| 2023-03-09 16:12:11 -0600 | Rating Details | |
| 2023-03-21 18:19:23 -0500 | Rating Details | |
| 2023-03-10 23:58:15 -0600 | Rating Details | |
| 2023-03-10 22:31:18 -0600 | Rating Details | |
| 2023-03-21 21:55:48 -0500 | Rating Details | |
| 2023-03-08 15:51:57 -0600 | Rating Details | |
| 2023-03-10 23:29:22 -0600 | Rating Details | |
| 2023-03-09 00:40:18 -0600 | Rating Details | |
| 2023-03-08 15:49:48 -0600 | Rating Details | |
| 2023-03-10 23:00:43 -0600 | Rating Details | |
| 2023-03-11 00:14:46 -0600 | Rating Details | |
| 2023-03-08 15:43:24 -0600 | Rating Details | |
| 2023-03-10 23:19:23 -0600 | Rating Details | |
| 2023-03-13 21:15:53 -0500 | Rating Details | |
| 2023-03-10 21:47:52 -0600 | Rating Details | |
| 2023-03-09 22:02:56 -0600 | Rating Details | |
| 2023-03-09 23:18:38 -0600 | Rating Details | |
| 2023-03-21 20:02:29 -0500 | Rating Details | |
| 2023-03-10 23:35:15 -0600 | Rating Details | |
| 2023-03-10 23:54:14 -0600 | Rating Details |